Students' Scientific Group of Rheumatology and Immunology, Jagiellonian University Medical College, Krakow, Poland.
Department of Rheumatology and Immunology, Jagiellonian University Medical College, Krakow, Poland.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2173912. doi: 10.1080/21645515.2023.2173912. Epub 2023 Feb 6.
The rapid development of COVID-19 vaccines became essential for addressing the global pandemic. Reactive arthritis after vaccination has been a rare phenomenon. Here, we present a case series of three patients with joint inflammation possibly attributed to COVID-19 immunization (mRNA and live adenovirus vectored vaccine). Symptoms were alleviated using non-steroid anti-inflammatory drugs and glucocorticoids. After follow-up, the patients have not been diagnosed with any other rheumatic disease. Reactive arthritis after the COVID-19 vaccine is an unusual adverse effect and poses a negligible risk in comparison to the benefits of immunization, but it should be considered in differential diagnostics by a practicing rheumatologist who cares for patients with new-onset arthritis without apparent cause at the time of pandemic.
译文:
新冠疫苗的快速发展对于应对全球大流行至关重要。疫苗接种后发生反应性关节炎是一种罕见现象。在这里,我们报告了三例可能与 COVID-19 免疫(mRNA 和活腺病毒载体疫苗)相关的关节炎症患者病例系列。使用非甾体抗炎药和糖皮质激素缓解了症状。随访后,患者未被诊断出患有任何其他风湿性疾病。新冠疫苗接种后的反应性关节炎是一种不常见的不良反应,与免疫接种的益处相比,风险可以忽略不计,但在大流行期间,当出现无明显原因的新发关节炎时,治疗关节炎的风湿病医生在鉴别诊断中应考虑这一因素。